Glaucia C Akutagava-Martins1, Angelica Salatino-Oliveira1, Christian Kieling1, Julia P Genro1, Guilherme V Polanczyk1, Luciana Anselmi1, Ana M B Menezes1, Helen Gonçalves1, Fernando C Wehrmeister1, Fernando C Barros1, Sidia M Callegari-Jacques1, Luis A Rohde1, Mara H Hutz1. 1. From the Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil (Akutagava-Martins, Salatino-Oliveira, Genro, Hutz); the Child and Adolescent Psychiatry Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil (Kieling, Rohde); the Department of Psychiatry, Universidade de São Paulo, São Paulo, São Paulo, Brazil (Polanczyk); the Graduate Program in Epidemiology, Universidade Federal de Pelotas, Pelotas, Rio Grande do Sul, Brazil (Anselmi, Menezes, Gonçalves, Wehrmeister, Barros); the Graduate Program in Health and Behavior, Universidade Católica de Pelotas, Pelotas, Rio Grande do Sul, Brazil (Barros); the Department of Statistics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil (Callegari-Jacques); and the Institute for Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil (Polanczyk, Rohde).
Abstract
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) symptoms are dimensionally distributed in the population. This study aimed to assess the role of the catechol-O-methyltransferase (COMT) and of the dopamine transporter (DAT1) genes on ADHD symptoms in the general population. METHODS: We investigated 4101 individuals from the 1993 Pelotas Birth Cohort Study using the parent version of the Strengths and Difficulties Questionnaire (SDQ) at ages 11 and 15 years. The SDQ hyperactivity/inattention scores were the main outcomes. RESULTS: Linear regression analyses demonstrated that the increasing number of COMT158Val and DAT1 10R alleles significantly predicted increasing SDQ hyperactivity/inattention scores in boys at both 11 and 15 years of age (β coefficient = 0.049, t = 2.189, p = 0.029, R2 = 0.012, and β coefficient = 0.064, t = 2.832, p = 0.005, R2 = 0.008, respectively). The presence of both COMT158Val and DAT1 10R alleles was also associated with full categorical ADHD diagnosis at 18 years of age in boys (χ2 = 4.561, p = 0.033, odds ratio 2.473, 95% confidence interval 1.048-5.838) from this cohort. We did not observe these associations in girls. LIMITATIONS: Our analyses of SDQ hyperactivity/inattention scores were not corrected for SDQ scores of conduct problems because these variables were highly correlated. CONCLUSION: This study demonstrates a role for COMT and DAT1 genes on hyperactivity/inattention symptoms and provides further support for ADHD as the extreme of traits that vary in the population. It also confirms previous evidence for sexual dimorphism on COMT and DAT1 gene expression.
BACKGROUND:Attention-deficit/hyperactivity disorder (ADHD) symptoms are dimensionally distributed in the population. This study aimed to assess the role of the catechol-O-methyltransferase (COMT) and of the dopamine transporter (DAT1) genes on ADHD symptoms in the general population. METHODS: We investigated 4101 individuals from the 1993 Pelotas Birth Cohort Study using the parent version of the Strengths and Difficulties Questionnaire (SDQ) at ages 11 and 15 years. The SDQ hyperactivity/inattention scores were the main outcomes. RESULTS: Linear regression analyses demonstrated that the increasing number of COMT158Val and DAT1 10R alleles significantly predicted increasing SDQ hyperactivity/inattention scores in boys at both 11 and 15 years of age (β coefficient = 0.049, t = 2.189, p = 0.029, R2 = 0.012, and β coefficient = 0.064, t = 2.832, p = 0.005, R2 = 0.008, respectively). The presence of both COMT158Val and DAT1 10R alleles was also associated with full categorical ADHD diagnosis at 18 years of age in boys (χ2 = 4.561, p = 0.033, odds ratio 2.473, 95% confidence interval 1.048-5.838) from this cohort. We did not observe these associations in girls. LIMITATIONS: Our analyses of SDQ hyperactivity/inattention scores were not corrected for SDQ scores of conduct problems because these variables were highly correlated. CONCLUSION: This study demonstrates a role for COMT and DAT1 genes on hyperactivity/inattention symptoms and provides further support for ADHD as the extreme of traits that vary in the population. It also confirms previous evidence for sexual dimorphism on COMT and DAT1 gene expression.
Authors: Angélica Salatino-Oliveira; Julia P Genro; Ana P Guimarães; Rodrigo Chazan; Cristian Zeni; Marcelo Schmitz; Guilherme Polanczyk; Tatiana Roman; Luis A Rohde; Mara H Hutz Journal: J Neural Transm (Vienna) Date: 2012-01-21 Impact factor: 3.575
Authors: Rhoshel K Lenroot; Nitin Gogtay; Deanna K Greenstein; Elizabeth Molloy Wells; Gregory L Wallace; Liv S Clasen; Jonathan D Blumenthal; Jason Lerch; Alex P Zijdenbos; Alan C Evans; Paul M Thompson; Jay N Giedd Journal: Neuroimage Date: 2007-04-06 Impact factor: 6.556
Authors: J J Sandra Kooij; Jan K Buitelaar; Edwin J van den Oord; Johan W Furer; Cees A Th Rijnders; Paul P G Hodiamont Journal: Psychol Med Date: 2005-06 Impact factor: 7.723
Authors: K M Cornish; T Manly; R Savage; J Swanson; D Morisano; N Butler; C Grant; G Cross; L Bentley; C P Hollis Journal: Mol Psychiatry Date: 2005-07 Impact factor: 15.992
Authors: Keeley J Brookes; Benjamin M Neale; Karen Sugden; Nadeem Khan; Philip Asherson; Ursula M D'Souza Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-12-05 Impact factor: 3.568
Authors: Michael C Monuteaux; Joseph Biederman; Alysa E Doyle; Eric Mick; Stephen V Faraone Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-07 Impact factor: 8.829
Authors: Benjamin Dirlikov; Keri Shiels Rosch; Deana Crocetti; Martha B Denckla; E Mark Mahone; Stewart H Mostofsky Journal: Neuroimage Clin Date: 2014-12-10 Impact factor: 4.881
Authors: Christian Kieling; Mara H Hutz; Júlia P Genro; Guilherme V Polanczyk; Luciana Anselmi; Suzi Camey; Pedro C Hallal; Fernando C Barros; Cesar G Victora; Ana M B Menezes; Luis Augusto Rohde Journal: J Child Psychol Psychiatry Date: 2012-12-07 Impact factor: 8.982
Authors: Molly A Kwiatkowski; Zackary A Cope; Maria L Lavadia; Chuck J A van de Cappelle; Davide Dulcis; Jared W Young Journal: Sci Rep Date: 2020-06-23 Impact factor: 4.379
Authors: Paula Rovira; Ditte Demontis; Anders D Børglum; Barbara Franke; Josep Antoni Ramos-Quiroga; María Soler Artigas; Marta Ribasés; Cristina Sánchez-Mora; Tetyana Zayats; Marieke Klein; Nina Roth Mota; Heike Weber; Iris Garcia-Martínez; Mireia Pagerols; Laura Vilar-Ribó; Lorena Arribas; Vanesa Richarte; Montserrat Corrales; Christian Fadeuilhe; Rosa Bosch; Gemma Español Martin; Peter Almos; Alysa E Doyle; Eugenio Horacio Grevet; Oliver Grimm; Anne Halmøy; Martine Hoogman; Mara Hutz; Christian P Jacob; Sarah Kittel-Schneider; Per M Knappskog; Astri J Lundervold; Olga Rivero; Diego Luiz Rovaris; Angelica Salatino-Oliveira; Bruna Santos da Silva; Evgeniy Svirin; Emma Sprooten; Tatyana Strekalova; Alejandro Arias-Vasquez; Edmund J S Sonuga-Barke; Philip Asherson; Claiton Henrique Dotto Bau; Jan K Buitelaar; Bru Cormand; Stephen V Faraone; Jan Haavik; Stefan E Johansson; Jonna Kuntsi; Henrik Larsson; Klaus-Peter Lesch; Andreas Reif; Luis Augusto Rohde; Miquel Casas Journal: Neuropsychopharmacology Date: 2020-04-12 Impact factor: 7.853
Authors: Alessandra Cirillo; Elton Diniz; Ary Gadelha; Elson Asevedo; Luiza K Axelrud; Eurípedes C Miguel; Luis Augusto Rohde; Rodrigo A Bressan; Pedro Pan; Jair de J Mari Journal: Braz J Psychiatry Date: 2020-04-03 Impact factor: 2.697
Authors: Mirian Sánchez-Morán; Juan Andrés Hernández; Jon Andoni Duñabeitia; Adelina Estévez; Laura Bárcena; Aintzane González-Lahera; María Teresa Bajo; Luis J Fuentes; Ana M Aransay; Manuel Carreiras Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240